February 25-26, 2020 Meeting of the Iowa Board of Pharmacy

Meeting Information
Meeting Time: 
Tuesday, February 25, 2020 - 1:00pm to Wednesday, February 26, 2020 - 4:30pm
Meeting Location: 
Iowa Board of Pharmacy
400 SW 8th St Ste H
Des Moines, IA 50309
Agenda
Meeting Agenda: 

1:00 p.m.        Call to Order & Announcements

Closed Session Agenda—these agenda items will be handled in closed session after the conclusion of the hearing. For closed session agenda items requiring final action, the Board will vote on these items in open session.

Motion to go into closed session pursuant to Iowa Code section 21.5(1)(a), to review or discuss records which are required or authorized by state or federal law to be kept confidential; pursuant to Iowa Code section 21.5(1)(d), to discuss whether to initiate licensee disciplinary investigations or proceedings; and pursuant to Iowa Code section 21.5(1)(f), to discuss the decision to be rendered in a contested case conducted according to the provisions of Iowa Code chapter 17A, and 21.5(1)(h) to avoid disclosure of specific law enforcement matters, such as allowable tolerances or criteria for the selection, prosecution, or settlement of cases, which if disclosed would facilitate disregard of requirements imposed by law.                           

  1. Review of Closed Session Minutes – 21.5(1)(a)
    1. January 7-8, 2020 Closed Session Minutes
  2. Complaints and Investigative Reports – 21.5(1)(d)
  3. Combined Statement of Charges, Settlement Agreement and Final Orders – 21.5(1)(d) & (f)
  4. Findings of Fact, Conclusions of Law, Decision and Order – 21.5(1)(f)
    1. 2019-0049 - Amanda Haugen, CPhT, Registration 17633, Forest City
    2. 2010-72 – Kathy Simonton, CPhT Registration 4159, Montezuma
  5. Discussion of criteria and authority for administrative approval of certain petitions – 21.5(1)(h)

Return to Open Session

Vote on any closed session agenda items requiring final action

Recess until February 26, 2020 at 9:00 a.m.

There is no waiting room and the doors will not open until a few minutes prior to the start of the meeting at 9:00 a.m.

9:00 a.m.         Call to Order & Announcements

Public Comment Period—anyone who has submitted material for the agenda will be given an opportunity to address the Board during the particular agenda item.  A member of the public wishing to address the Board regarding a particular agenda item should raise a hand during that agenda item to be recognized. During the initial public comment period, members of the public will have the opportunity to address the Board regarding any items not on the agenda, or any agenda item if the person is unable to be present for the discussion of the particular agenda item. Acknowledgment and an opportunity to speak will be limited to 5 minutes per person, with additional time allowed at the discretion of the chairperson.

Approval of Minutes

  1. January 7-8, 2020 Open Session Minutes

Requests

  1. Technician-Administered Immunization Project Application – Hy-Vee, Inc.
  2. Request to waive 657 IAC 17.3(1)“c” requiring evidence of current verified-accredited wholesale distributors (VAWD) accreditation by the NABP – Iowa Department of Public Health, License 8312, Des Moines
  3. Request to waive 657 IAC 17.3(1)“c” requiring evidence of current verified-accredited wholesale distributors (VAWD) accreditation by the NABP – Allegis Pharmaceuticals, LLC, License 7563, Canton, MS
  4. Request to waive 657 IAC 17.3(1)“c” requiring evidence of current verified-accredited wholesale distributors (VAWD) accreditation by the NABP – Amneal Pharmaceuticals, LLC, License 6667, Glasgow, KY
  5. Request to waive 657 IAC 17.3(1)“c” requiring evidence of current verified-accredited wholesale distributors (VAWD) accreditation by the NABP – Amneal Pharmaceuticals, LLC, License 7986, Glasgow, KY
  6. Request to waive 657 IAC 17.3(1)“c” requiring evidence of current verified-accredited wholesale distributors (VAWD) accreditation by the NABP – Crown Pharmaceuticals, Inc., License 7707, Harahan, LA
  7. Request to waive 657 IAC 17.3(1)“c” requiring evidence of current verified-accredited wholesale distributors (VAWD) accreditation by the NABP – Danox Environmental Services, Inc., License 7944, Cumming, GA
  8. Request to waive 657 IAC 17.3(1)“c” requiring evidence of current verified-accredited wholesale distributors (VAWD) accreditation by the NABP – CutisPharma, Inc., License 5090, Wilminton, MA
  9. Request to waive 657 IAC 17.3(1)“c” requiring evidence of current verified-accredited wholesale distributors (VAWD) accreditation by the NABP – Fluvaccine.org Inc., License 8319, San Diego, CA
  10. Request to waive 657 IAC 17.3(1)“c” requiring evidence of current verified-accredited wholesale distributors (VAWD) accreditation by the NABP – Medline Industries, Inc., License 6976, Kansas City, MO
  11. Request to waive 657 IAC 17.3(1)“c” requiring evidence of current verified-accredited wholesale distributors (VAWD) accreditation by the NABP – Northwind Pharmaceuticals, LLC, License 5698, Indianapolis, IN
  12. Request to waive 657 IAC 17.3(1)“c” requiring evidence of current verified-accredited wholesale distributors (VAWD) accreditation by the NABP – South Pointe Wholesale, Inc., License 6047, Glasgow, KY
  13. Request to waive 657 IAC 17.3(1)“c” requiring evidence of current verified-accredited wholesale distributors (VAWD) accreditation by the NABP – United Drug Supply, Inc., License 8226, Morrisville, NC
  14. Request to waive 657 IAC 43.3(1) requiring evidence of current verified-accredited wholesale distributors (VAWD) accreditation by the NABP – CEVA Freight, LLC, License 80049
  15. Request to waive 657 IAC 43.3(1) requiring evidence of current verified-accredited wholesale distributors (VAWD) accreditation by the NABP – FedEx Supply Chain, Inc., Applicant, Memphis, TN

Petitions for Exemption from Mandate for Electronic Transmission of Prescriptions

  1. Consent Agenda
  2. Block A
    1. Iowa Digestive Disease Center
  3. Block B
    1. Dr.s Geyer & Binzer, PC, Randall H. Binzer, DDS, MS
    2. A-1 Dental, Ankeny
    3. A-1 Dental, Urbandale
    4. Dr. Thomas Roed, DDS
    5. Dr. Robert Alt, DDS
  4. Block C
    1. Dr. Dave Motz, DDS
    2. Dr. Betsy Love, MD
    3. Metro Care Connection
    4. Crawford County Home Health
    5. Hope Haven, Inc
  5. Block D
    1. Dr. Gregory Peterson, DO
    2. Dr. Todd Conway, MD
  6. Block E
    1. Eldora Family Dentistry and Orthodontics
    2. Dr. Ann Connors, DDS
  7. Block F
    1. Dr. Kurtis Korver, MD
    2. A+ Iowa Dental
  8. Block G
    1. Adel Vision Clinic, LLC
  9. Block H
    1. Rebecca Nunn-Ryan, ARNP
    2. Sharon Hopkins-Brinegar, ARNP
    3. Above & Beyond Hospice
    4. Valerie Knedler, ARNP
    5. Robert Detlefsen, ARNP
    6. Jacquelene Garden, ARNP
    7. Siouxland Adult Medicine Clinic
    8. Pulmonary Infectious Disease Assoc. PC
    9. Dr. Karen Anersson, OP
    10. Drake Student Health

Licensure/Registration Applications

  1. Boca Pharmacy, Pharmacy Applicant, Bronx, NY
  2. Debra Sanders, PSP Applicant, Council Bluffs

Reports & Informational Items

  1. Executive Director’s Report
  2. Meetings and Travel
  3. PMP
  4. Medication Disposal Update
  5. IMP3 Report

Rules and Legislation

  1. Update on Legislation related to the Board, the Practice of Pharmacy, the PMP, and Controlled Substances.
  2. Proposed Termination of Rulemaking for Chapter 6, “General Pharmacy Practice,” (ARC 4694C)
  3. Proposed for Adoption and Filing to amend Chapter 17, “Wholesale Distributor Licenses,” Chapter 42, “Limited Distributor Licenses,” and Chapter 43, “Third-Party Logistics Provider Licenses,” (ARC 4691C)
  4. Proposed for Adoption and Filing to amend Chapter 8, “Universal Practice Standards,” (ARC 4695C)
  5. Proposed for Notice of Intended Action to amend Chapter 8, “Universal Practice Standards” to clarify that patient information which is needed for a pharmacist to conduct drug utilization review shall be obtained and that the collection of such information can be delegated to a pharmacy technician.
  6. Proposed for Notice of Intended Action to amend Chapter 1, “Purpose and Organization,” and Chapter 8, “Universal Practice Standards” to update language to be consistent with changes made to the Code during the 2019 legislative session.
  7. Vote on Nicotine-replacement Statewide Protocol
  8. Vote on Naloxone Statewide Protocol
  9. Vote on Immunizations Statewide Protocol

Possible Closed Session

Continuation of any unfinished business from the closed session agenda for February 25, 2020, will be held after the conclusion of the above agenda items.

Return to Open Session

Votes on any closed session agenda items requiring final action

Adjournment

 

 

Minutes
Meeting Minutes: 

This document is in PDF format.  Please contact the Board office at 515-281-6674 if assistance is required. 

Meeting Minutes Document: 
Meeting Materials

Printed from the Iowa Board of Pharmacy website on August 06, 2020 at 11:03am.